SCHEMBL22420294

SCHEMBL22420294

COc1ccc(C(O)c2cc3c(c(OC)c2)OC(C)(C)C=C3)cc1OC

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 11/20 0.46
▸ PDE4D Q08499 1/20 0.41
▸ PTPN1 P18031 1/20 0.41
▸ EPAS1 Q99814 3/20 0.41
▸ ACHE P22303 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ CASP1 P29466 1/20 0.40
▸ CASP7 P55210 1/20 0.40
▸ EP300 Q09472 1/20 0.40
▸ PPARG P37231 1/20 0.39
▸ PPARD Q03181 1/20 0.39
▸ PPARA Q07869 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA7 P43166 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ CA13 Q8N1Q1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16694505 0.86 HIF1A (0.55) HIF1AEPAS1EP300HSP90AA1
SCHEMBL6656697 0.74 PPARG (0.61) ACHEPPARGPPARDPPARACA12
SCHEMBL10071255 0.72 PDE4D (0.53) HIF1APDE4DPTPN1EPAS1KDM4E
SCHEMBL22420346 0.72 HTT (0.41) HIF1APDE4DACHEPPARGPPARD
SCHEMBL22420260 0.71 HIF1A (0.50) HIF1AEPAS1ACHEEP300HSP90AA1
SCHEMBL31239009 0.69 LMNA (0.46) PDE4DPTPN1KDM4ECASP1CASP7
SCHEMBL5476809 0.69 LMNA (0.46) PDE4DPTPN1KDM4ECASP1CASP7
SCHEMBL22420303 0.69 HIF1A (0.46) HIF1AEPAS1
SCHEMBL6795851 0.68 ODC1 (0.46) PDE4DPTPN1KDM4ECASP1CASP7
SCHEMBL16694230 0.68 HIF1A (0.67) HIF1AEPAS1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10772858-B2 Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2020-09-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10772858-B2 Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors HIF1A, HIF1AN, EGLN2 HIF1A 1/4885PDE4D 1272/4885PTPN1 4019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback